Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

The Non-Malignant Channel:
Cold Agglutinin Disease

Explore the latest updates and expert interviews

Welcome to The Cold Agglutinin Disease (CAD) Channel

The Cold Agglutinin Disease Channel brings you pivotal updates on this rare form of autoimmune hemolytic anemia presented at major international congresses. Explore our exclusive interviews with field leaders to get the latest news on the treatment and management of CAD, including the development of novel complement-directed therapies, disease prognosis, and epidemiology.

Practice-changing potential from Cardinal: sutimlimab in CAD 6:28
Practice-changing potential from Cardinal: sutimlimab in CAD
Alexander Röth • 10 Dec 2019

Choose your cookie settings

VJHemOnc uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJHemOnc is intended for healthcare professionals